Clark Eliana — SEC Form 4 filings

SEC reporting owner CIK 1914448. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-05 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intellia Therapeutics, Inc. (NTLA)EVP, Chief Technical Officer66 legs · 12,833 sh · $141,3836

Form 4 filings — Clark Eliana

FiledFormIssuerReported transactionsSource
2026-03-034Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 7,353 @ $0 · Sale (S): 607 @ $13.78 · Grant/award (A): 10,505 (derivative) @ $0EDGAR
2026-01-074Intellia Therapeutics, Inc. (NTLA)Sale (S): 9,515 @ $9.21EDGAR
2025-07-034Intellia Therapeutics, Inc. (NTLA)Sale (S): 1,022 @ $9.82EDGAR
2025-03-044Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 32,000 @ $0 · Sale (S): 679 @ $8.99 · Grant/award (A): 45,714 (derivative) @ $0EDGAR
2024-07-034Intellia Therapeutics, Inc. (NTLA)Sale (S): 405 @ $22.93EDGAR
2024-03-054Intellia Therapeutics, Inc. (NTLA)Grant/award (A): 31,230 @ $0 · Sale (S): 605 @ $32.99 · Grant/award (A): 45,072 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1914448 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →